This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Comparison of primary and secondary Raynaud's phenomenon

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • primary RP - generally begins during the teens and early 20's; represents an exaggerated physiological response to cold stimuli (1); not generally associated with any other disease entity
    • symmetrical involvement
    • no tissue necrosis or gangrene
    • ESR normal
    • normal nail fold capillaries
    • negative for anti nuclear antibodies (2,4)

  • secondary RP - the development of RP at an older age (i.e. > 30 years), and particularly in males, suggests the possibility that RP is secondary to some underlying connective tissue disease (CTD) (1). RP occurs in over 90% of patients with systemic sclerosis and in up to 40% of patients with systemic lupus erythematosus and idiopathic inflammatory myositis(1). Features that make a secondary cause of RP more likely include:
    • digital ulceration, or year-round symptoms
    • pain and discomfort is higher in severity
    • abnormal nail fold capillaries (viewed with an ophthalmoscope with the +20 lens)
    • assymetric upper limb pulses or bruits
    • puffiness/tightness of the finger skin
    • a raised ESR
    • positive ANA or other antibodies (Ro/La/Scl-70 etc)
    • clinical features suggestive of an underlying connective tissue disease (3,4)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.